OBJECTIVE: The relationship between weight status and asthma characteristics in children remains inadequately defined. Very little has been published on the risk of exacerbation, physician perception of severity, and the level controller treatment prescribed to underweight and obese children with asthma in a real-world setting. METHODS: We assessed the diagnostic severity, pulmonary function, exacerbation prevalence, and controller treatment level in 10,559 new asthma patients seen at one of four pediatric asthma subspecialty clinics among three BMI groups. Participants were analyzed by body mass index (BMI)-percentile based on Centers for Disease Control & Prevention classification. Multivariable logistic regression models were used to assess the associations between BMI-percentile cohort group and asthma outcomes. RESULTS. Underweight asthmatics were rare (2.5%) relative to obese asthmatics but appeared to have the greatest impairment in forced vital capacity and had the greatest controller treatment burden. Obese asthmatic children made up 26.2% of our cohort and were more likely to have severe disease (odds ratio (OR) 1.40, 95% confidence interval (CI) 1.06-1.85) and airflow obstruction (OR 1.36, 95% CI 1.16-1.59) compared to normal weight asthmatics. Obese asthmatics were not at greater risk for exacerbation (OR 1.41, 95% CI 0.64-3.11) or high treatment burden (OR 1.03, 95% CI 0.83-1.28). CONCLUSIONS. Obesity is more common than underweight status among children with asthma. Both underweight and obese children with asthma have worse lung function and asthma-related outcomes compared to similar normal weight children, though the phenotypic characteristics of underweight and obese asthmatics differed considerably.
OBJECTIVE: The relationship between weight status and asthma characteristics in children remains inadequately defined. Very little has been published on the risk of exacerbation, physician perception of severity, and the level controller treatment prescribed to underweight and obesechildren with asthma in a real-world setting. METHODS: We assessed the diagnostic severity, pulmonary function, exacerbation prevalence, and controller treatment level in 10,559 new asthmapatients seen at one of four pediatric asthma subspecialty clinics among three BMI groups. Participants were analyzed by body mass index (BMI)-percentile based on Centers for Disease Control & Prevention classification. Multivariable logistic regression models were used to assess the associations between BMI-percentile cohort group and asthma outcomes. RESULTS. Underweight asthmatics were rare (2.5%) relative to obese asthmatics but appeared to have the greatest impairment in forced vital capacity and had the greatest controller treatment burden. Obese asthmatic children made up 26.2% of our cohort and were more likely to have severe disease (odds ratio (OR) 1.40, 95% confidence interval (CI) 1.06-1.85) and airflow obstruction (OR 1.36, 95% CI 1.16-1.59) compared to normal weight asthmatics. Obese asthmatics were not at greater risk for exacerbation (OR 1.41, 95% CI 0.64-3.11) or high treatment burden (OR 1.03, 95% CI 0.83-1.28). CONCLUSIONS. Obesity is more common than underweight status among children with asthma. Both underweight and obesechildren with asthma have worse lung function and asthma-related outcomes compared to similar normal weight children, though the phenotypic characteristics of underweight and obese asthmatics differed considerably.
Authors: Jason E Lang; Janet T Holbrook; Robert A Wise; Anne E Dixon; W Gerald Teague; Christine Y Wei; Charles G Irvin; David Shade; John J Lima Journal: Pediatr Pulmonol Date: 2012-11-09
Authors: Jason E Lang; Anne M Fitzpatrick; David T Mauger; Theresa W Guilbert; Daniel J Jackson; Robert F Lemanske; Fernando D Martinez; Robert C Strunk; Robert S Zeiger; Wanda Phipatanakul; Leonard B Bacharier; Jacqueline A Pongracic; Fernando Holguin; Michael D Cabana; Ronina A Covar; Hengameh H Raissy; Monica Tang; Stanley J Szefler Journal: J Allergy Clin Immunol Date: 2017-12-19 Impact factor: 10.793
Authors: Deepa Rastogi; John Nico; Andrew D Johnston; Toni Adrianne M Tobias; Yurydia Jorge; Fernando Macian; John M Greally Journal: J Allergy Clin Immunol Date: 2017-05-04 Impact factor: 10.793
Authors: Paul H Dahm; Jeremy B Richards; Harry Karmouty-Quintana; Kevin R Cromar; Sanjiv Sur; Roger E Price; Farhan Malik; Chantal Y Spencer; Ramon X Barreno; Syed S Hashmi; Michael R Blackburn; Ikram U Haque; Richard A Johnston Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-07-09 Impact factor: 3.619
Authors: Kim D Lu; Wanda Phipatanakul; Matthew S Perzanowski; Susan Balcer-Whaley; Elizabeth C Matsui Journal: J Asthma Date: 2016-05-04 Impact factor: 2.515
Authors: Deepa Rastogi; Sasha Fraser; Jamie Oh; Ashley M Huber; Yael Schulman; Renuka H Bhagtani; Zeeshan S Khan; Lydia Tesfa; Charles B Hall; Fernando Macian Journal: Am J Respir Crit Care Med Date: 2015-01-15 Impact factor: 30.528
Authors: Maartje Willeboordse; Kim D G van de Kant; Maroeska N de Laat; Onno C P van Schayck; Sandra Mulkens; Edward Dompeling Journal: BMC Public Health Date: 2013-05-21 Impact factor: 3.295